Description: Health care is a complex market with a wide variety of stakeholders. These stakeholders have diverse business needs, requiring complicated data-driven decisions. The analytics and research supporting these decisions are often dependent on the availability of real-world data (RWD), which includes a wide variety of data capture technology and data reflecting treatment, clinical outcomes, and costs of health care in real treatment settings (e.g.,, outside of controlled clinical trials). The goal of this panel discussion is to explore how existing and emerging sources of RWD can enhance benefit design, improve risk assessment, influence treatment decisions, and advance the measurement of clinical, humanistic, and financial outcomes. The diverse speaker panel includes actuarial and non-actuarial perspectives, representing the pharmaceutical industry, a health-care services business, and academia. The panel will describe the decision-making that drives their individual needs to use RWD, identify current and developing RWD sources, provide examples of analyses using RWD, and discuss how emerging RWD may influence actuarial analytics and potentiate the development of new interdisciplinary methods and value drivers.

Description: Ignite presentations feature speakers with 20 slides which automatically advance every 15 seconds. The result is a fast and fun presentation which lasts just five minutes. The first portion of this session will feature public health experts doing Ignite presentations with particular focus on social determinants and health disparities. Then stick around for the second portion when all of the presenters take part in a moderated, talk show-style discussion. You'll get a chance to ask your questions and dig deeper into the topics you just heard about. Be prepared for a fast-paced, thought-provoking session that you'll remember long after it ends!

Description: The SOA is pleased to make available a research report providing insight and considerations for the actuarial profession in assessing the potential risk and opportunities of MACRA to both provider and payer organizations.